Every trade Ashley Moody (U.S. Senate, Florida) disclosed under the STOCK Act: what was bought and sold, how the stock purchases did against the S&P 500 and how long each disclosure took. Data as of Oct 20, 2026.
Ashley Moody (U.S. Senate, Florida) disclosed 37 trades between Jan 21, 2025 and Apr 4, 2025 in STOCK Act periodic transaction reports, 19 of them in individual stocks: 14 purchases and 5 sales. Their estimated volume is $2.0 million, from the midpoints of the disclosed ranges. Every trade was in a self or joint account.
| Measure | Ashley Moody |
|---|---|
| Chamber | U.S. Senate, Florida |
| Trades disclosed | 37 |
| Stock trades | 19 (14 buys, 5 sales) |
| First and latest trade | Jan 21, 2025 – Apr 4, 2025 |
| Estimated volume | $2.0 million |
| Account owner | Self or joint 100% |
| Stock | Company | Trades |
|---|---|---|
| SMCI | Super Micro Computer, Inc. | 4 |
| HWM | Howmet Aerospace Inc. | 3 |
| AMAT | Applied Materials, Inc. | 3 |
| NVDA | NVIDIA Corporation | 2 |
| JPM | JPMorgan Chase & Co. | 1 |
| ARCC | Ares Capital Corporation | 1 |
| ET | Energy Transfer LP | 1 |
| LLY | Eli Lilly and Company | 1 |
| AMD | Advanced Micro Devices, Inc. | 1 |
| MU | Micron Technology, Inc. | 1 |
By sector: Technology (12), Industrials (3), Financial Services (2), Energy (1), Healthcare (1). Counts of disclosed trades in each stock, buys and sales together, before the last 30 days.
Exent scored 14 disclosed stock purchases by Ashley Moody against the S&P 500. Over the 12 months after each trade they beat the S&P 500 by an average of 44.2 percentage points, and 71.4% of the 14 purchases that are a year old beat the index. Measured from the disclosure date, the first day the public could see each trade, the 12‑month figure was +60.4%. Ashley Moody is not ranked: the ranking needs at least 20 purchases that are a year old.
| Measure | Ashley Moody | All members |
|---|---|---|
| Stock buys scored | 14 | 24,613 |
| Average vs S&P 500, 3 months | +0.6% | −0.1% |
| Average vs S&P 500, 12 months | +44.2% | −0.4% |
| Buys that beat it over 12 months | 71.4% | 43.2% |
| 12 months from the disclosure date | +60.4% | −0.8% |
| Rank | Not ranked | — |
The 10 members with the best records by this measure are named in Exent Radar, with their latest trades.
All 37 of Ashley Moody’s disclosed trades were reported within the STOCK Act’s 45‑day deadline; the median trade was disclosed 30 days after it was made.
| Measure | Ashley Moody | All members |
|---|---|---|
| Median days to disclose | 30 days | 28 days |
| Disclosed after 45 days | 0.0% | 14.9% |
| Longest delay | 40 days | — |
Trades disclosed before Sep 20, 2026 are listed below, newest first, each with a link to the original filing.
| Trade date | Stock | Trade | Amount | Disclosed after |
|---|---|---|---|---|
| Apr 4, 2025 | HWM | Buy (self) | $15,001–$50,000 | 40 days · filing |
| Apr 4, 2025 | JPM | Buy (self) | $15,001–$50,000 | 40 days · filing |
| Apr 4, 2025 | ARCC | Buy (self) | $15,001–$50,000 | 40 days · filing |
| Apr 4, 2025 | ET | Buy (self) | $15,001–$50,000 | 40 days · filing |
| Mar 25, 2025 | SUPER MICRO COMPUTER INC (1) | Sale (self) | $1,001–$15,000 | 26 days · filing |
| Mar 25, 2025 | SMCI | Buy (self) | $100,001–$250,000 | 26 days · filing |
| Mar 25, 2025 | NVIDIA Corporation | Sale (self) | $1,001–$15,000 | 26 days · filing |
| Mar 24, 2025 | SMCI | Sale (self) | $15,001–$50,000 | 27 days · filing |
| Mar 21, 2025 | NVDA | Buy (self) | $15,001–$50,000 | 30 days · filing |
| Mar 20, 2025 | NVDA | Buy (self) | $100,001–$250,000 | 31 days · filing |
| Mar 6, 2025 | LLY | Buy (self) | $100,001–$250,000 | 17 days · filing |
| Feb 24, 2025 | SMCI | Sale (self) | $50,001–$100,000 | 27 days · filing |
| Feb 24, 2025 | HWM | Sale (self) | $50,001–$100,000 | 27 days · filing |
| Feb 24, 2025 | SMCI | Sale (self) | $15,001–$50,000 | 27 days · filing |
| Feb 24, 2025 | AMD | Buy (self) | $100,001–$250,000 | 27 days · filing |
| Feb 24, 2025 | Norwegian Cruise Line Holdings Ltd (2) | Sale (self) | $1,001–$15,000 | 27 days · filing |
| Feb 24, 2025 | Applied Materials Inc | Sale (self) | $1,001–$15,000 | 27 days · filing |
| Feb 24, 2025 | Carnival Corporation & PLC | Sale (self) | $1,001–$15,000 | 27 days · filing |
| Jan 27, 2025 | AMAT PUT | Sale (self) | $1,001–$15,000 | 25 days · filing |
| Jan 27, 2025 | AMAT | Buy (self) | $100,001–$250,000 | 25 days · filing |
| Jan 27, 2025 | AMAT CALL | Sale (self) | $1,001–$15,000 | 25 days · filing |
| Jan 27, 2025 | NCLH CALL | Sale (self) | $1,001–$15,000 | 25 days · filing |
| Jan 27, 2025 | NVDA PUT | Sale (self) | $1,001–$15,000 | 25 days · filing |
| Jan 23, 2025 | DELL CALL | Sale (self) | $1,001–$15,000 | 29 days · filing |
| Jan 22, 2025 | AMAT CALL | Sale (self) | $1,001–$15,000 | 30 days · filing |
| Trade date | Stock | Trade | Amount | Disclosed after |
|---|---|---|---|---|
| Jan 22, 2025 | NVDA PUT | Sale (self) | $1,001–$15,000 | 30 days · filing |
| Jan 22, 2025 | MU | Buy (self) | $50,001–$100,000 | 30 days · filing |
| Jan 22, 2025 | SMCI PUT | Sale (self) | $1,001–$15,000 | 30 days · filing |
| Jan 22, 2025 | CCL CALL | Sale (self) | $1,001–$15,000 | 30 days · filing |
| Jan 22, 2025 | AMAT | Buy (self) | $100,001–$250,000 | 30 days · filing |
| Jan 22, 2025 | HWM | Buy (self) | $50,001–$100,000 | 30 days · filing |
| Jan 22, 2025 | AMD CALL | Sale (self) | $1,001–$15,000 | 30 days · filing |
| Jan 22, 2025 | MU CALL | Sale (self) | $1,001–$15,000 | 30 days · filing |
| Jan 22, 2025 | HWM CALL | Sale (self) | $1,001–$15,000 | 30 days · filing |
| Jan 22, 2025 | SMCI CALL | Sale (self) | $1,001–$15,000 | 30 days · filing |
| Jan 21, 2025 | AMAT | Buy (self) | $100,001–$250,000 | 31 days · filing |
| Jan 21, 2025 | OKTA | Sale (self) | $50,001–$100,000 | 31 days · filing |
Members of Congress report each trade over $1,000 in stocks, bonds and other securities, by themselves, their spouse or dependent children, in periodic transaction reports under the STOCK Act, filed with the House Clerk and the Senate. A trade must be reported within 45 days. Exent reads these public financial disclosures; every trade listed here links to its original filing.
Amounts are disclosed as ranges ($1,001–$15,000, $15,001–$50,000 and up), so dollar volumes are estimates from the midpoint of each range. Returns compare each disclosed purchase of a listed stock with the S&P 500 (SPY): total return with dividends from the close on the trade date to 3 and 12 months later, and again from the disclosure date, the first day the public could see the trade. Sales are not scored. The ranking covers members with at least 20 purchases that are a year old.
Trades disclosed in the last 30 days are counted but not listed; they are in Exent Radar, with the records of the top 10 performers. The disclosures carry no party labels: this is the public record of what was traded and when it was disclosed. Data as of Oct 20, 2026. How to read a filing yourself: Congress stock trading: how to see what members bought.
Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.
In STOCK Act disclosures, the stocks Ashley Moody traded most often are SMCI (4 trades), HWM (3 trades), AMAT (3 trades), NVDA (2 trades), JPM (1 trade). Of 37 disclosed trades, 19 were in individual stocks. Periodic transaction reports show trades, not full holdings.
Ashley Moody's disclosed stock purchases beat the S&P 500 by an average of 44.2 percentage points over the 12 months after each trade (14 purchases a year old), and 71.4% of them beat the index. Measured from the disclosure date the average was +60.4%. Past results do not predict future ones.
No: all 37 disclosed trades were reported within the STOCK Act's 45-day deadline. The median trade was disclosed 30 days after it was made; across Congress the median is 28 days.
Exent Radar shows trades by members of Congress, company insiders and big funds as they are disclosed, with the records of the top performers.
Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.